Related Experiment Video
Updated: Aug 10, 2026
08:49
Models of Bone Metastasis
Published on: September 4, 2012
Cardiac malignant pheochromocytoma with bone metastases
1Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical University.
Internal Medicine (Tokyo, Japan)
|December 30, 1998
Summary
A rare malignant cardiac pheochromocytoma with bone metastases was treated. While therapies offered partial symptom relief, the heart tumor grew, leading to fatal complications.
Area of Science:
- Cardiology
- Oncology
- Endocrinology
Background:
- Malignant pheochromocytoma is a rare neuroendocrine tumor originating from chromaffin cells.
- Cardiac pheochromocytoma is exceptionally rare, with limited data on its presentation and metastatic potential.
- Bone metastases from pheochromocytoma pose significant diagnostic and therapeutic challenges.
Observation:
- A patient presented with a malignant cardiac pheochromocytoma located between the pulmonary trunk and left atrium.
- Metastatic lesions were identified in the iliac bones.
- The patient exhibited elevated catecholamine levels and symptoms related to tumor burden.
Findings:
- Treatment with antihypertensive agents, alpha-methylparatyrosine, and combination chemotherapy (cyclophosphamide, vincristine, dacarbazine) provided temporary improvement.
- Partial response was observed in symptoms, catecholamine levels, and iliac bone metastases.
- The primary cardiac tumor showed progressive growth despite treatment.
Implications:
- This case highlights the aggressive nature and poor prognosis of malignant cardiac pheochromocytoma with distant metastases.
- Multimodal treatment strategies may offer palliation but are often insufficient to control advanced cardiac pheochromocytoma.
- Further research into novel therapeutic targets for advanced and metastatic pheochromocytoma is warranted.
